{
  "@context": {
    "bioagents": "https://bio.agents/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "owl": "http://www.w3.org/2002/07/owl#",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://doi.org/10.1101/2020.03.29.014381",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://doi.org/10.1101/2020.04.21.052084",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://doi.org/10.1101/2020.04.14.040204",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://bio.agents/sars-cov-2",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalAgent/0.6-DRAFT",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_3948"
        },
        {
          "@id": "edam:topic_0602"
        },
        {
          "@id": "edam:topic_3421"
        },
        {
          "@id": "edam:topic_3930"
        },
        {
          "@id": "edam:topic_3474"
        }
      ],
      "sc:citation": [
        {
          "@id": "https://doi.org/10.1101/2020.04.23.20076042"
        },
        {
          "@id": "https://doi.org/10.1101/2020.04.21.052084"
        },
        {
          "@id": "https://doi.org/10.1186/S40249-020-00650-1"
        },
        {
          "@id": "https://doi.org/10.1101/2020.04.02.021725"
        },
        {
          "@id": "https://doi.org/10.1101/2020.04.14.040204"
        },
        "pubmed:32264957",
        {
          "@id": "https://doi.org/10.1101/2020.03.29.014381"
        },
        "pmcid:PMC7137400",
        "pubmed:33196625",
        {
          "@id": "https://doi.org/10.1101/2020.04.09.034868"
        }
      ],
      "sc:description": "Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients.\n\nEnergetics based epitope screening in SARS CoV-2 (COVID 19) spike glycoprotein by Immuno-informatic analysis aiming to a suitable vaccine development.\n\na practice of building a community with a shared future for mankind.\n\nComputational Prediction of the Comprehensive SARS-CoV-2 vs. Human Interactome to Guide the Design of Therapeutics.\n\nArtificial intelligence predicts the immunogenic landscape of SARS-CoV-2.\n\nIdentification of Patient Characteristics Associated With SARS-CoV-2 Infection and Outcome in Kidney Transplant Patients Using Serological Screening.\n\nDe novo design of high-affinity antibody variable regions (Fv) against the SARS-CoV-2 spike protein.\n\nSevere Acute Respiratory Syndrome (SARS).",
      "sc:featureList": [
        {
          "@id": "edam:operation_3196"
        },
        {
          "@id": "edam:operation_0416"
        },
        {
          "@id": "edam:operation_0252"
        },
        {
          "@id": "edam:operation_0478"
        },
        {
          "@id": "edam:operation_2492"
        }
      ],
      "sc:license": "CC-BY-4.0",
      "sc:name": "SARS-CoV-2",
      "sc:url": "https://www.proteinatlas.org/humanproteome/sars-cov-2"
    },
    {
      "@id": "https://doi.org/10.1101/2020.04.23.20076042",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://doi.org/10.1186/S40249-020-00650-1",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://doi.org/10.1101/2020.04.09.034868",
      "@type": "sc:CreativeWork"
    },
    {
      "@id": "https://doi.org/10.1101/2020.04.02.021725",
      "@type": "sc:CreativeWork"
    }
  ]
}